.svg){kind=small}
Mar-2026
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Avexia has demonstrated varied performance across different states and product categories. In Arizona, the brand has made a notable entry into the Topical category, securing the 8th position in February 2026 and climbing to 6th by March 2026. This upward trajectory suggests growing consumer acceptance and demand for their topical products in the state. Meanwhile, in Illinois, Avexia has maintained a stronghold in the Capsules category, consistently ranking 2nd from December 2025 through March 2026. However, their performance in the Concentrates category in Illinois reveals some challenges, with a drop from the 26th position in February 2026 to 29th in March 2026, indicating potential areas for improvement or increased competition.
In Maryland, Avexia has shown resilience in the Capsules category, holding a steady 2nd position in March 2026 after a brief dip to 3rd in January 2026. Their Topical products also remain popular, reclaiming the top spot in March 2026 after a slight decline to 2nd in February. However, the brand did not appear in the top 30 for Concentrates in February, which could be a cause for concern. In New Jersey, Avexia's Topical category dominance is evident, consistently ranking 1st from January to March 2026. On the other hand, their Tincture & Sublingual products saw a minor dip from 2nd in February to 3rd in March, reflecting potential shifts in consumer preferences or market dynamics. Meanwhile, in Ohio, Avexia's performance in the Capsules category is noteworthy, with a climb back to the 5th position in March 2026 after not ranking in February, suggesting a recovery or strategic adjustments.
Competitive Landscape
In the Illinois Topical cannabis market, Avexia has consistently maintained its leading position, holding the number one rank from December 2025 through March 2026. This stability in rank highlights Avexia's strong market presence and customer loyalty. Despite a noticeable dip in sales from December 2025 to January 2026, Avexia's sales figures rebounded in the following months, indicating resilience and effective market strategies. In comparison, Doctor Solomon's has remained a close competitor, consistently ranked second except for a brief drop to third in February 2026, with significantly lower sales figures than Avexia. Meanwhile, Alchemy (Ieso) has shown improvement, climbing from fifth to fourth place by February 2026, though its sales remain far below those of Avexia. These dynamics suggest that while Avexia remains the dominant player, competitors are actively vying for market share, necessitating continuous innovation and customer engagement to maintain its top position.
Notable Products
In March 2026, Avexia's top-performing product was the CBD/THC 1:1 Harmony Pain Relief Balm with a sales figure of 7382, maintaining its position as the leading product since December 2025. The CBN/CBD/THC 1:1:1 Comfort Tablets held steady at the second rank, consistently performing well throughout the months. The CBD/THC 4:1 Relief Tablets secured the third position, showing a stable ranking since January 2026. The CBD/THC 1:1 Harmony Micro-Dosed Tablets ranked fourth, climbing up from the fifth position in January 2026. Lastly, the CBG/THC 1:1 Ascend Tablets remained in the fifth position, showing a slight decline in sales compared to previous months.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
